Literature DB >> 8668871

The incidence of cystic fibrosis.

M R Kosorok1, W H Wei, P M Farrell.   

Abstract

We develop a statistical model for estimating cystic fibrosis (CF) incidence among infants born in the U.S.A. that accounts for under-diagnosis due to death prior to diagnosis and we apply it to the Cystic Fibrosis Foundation Patient Registry data for the years 1989 to 1991. The resulting estimate of incidence relative to live births among whites is 1:3419 while that among non-whites is 1:12,163. As a by-product of the modelling approach, estimates of the underlying average diagnosis age given survival to diagnosis are 4.09 years for whites and 4.55 years for non-whites, but this difference was not statistically significant and appears to demonstrate that diagnosis efforts may be approximately the same for whites and non-whites. Also, as another by-product of the modelling approach, CF mortality was estimated as more severe for females than males and marginally more severe for non-whites than whites. A variety of statistical methods underlie achievement of these results, including semi-parametric maximum likelihood, survival analysis, multiple imputation and bootstrap techniques.

Entities:  

Mesh:

Year:  1996        PMID: 8668871     DOI: 10.1002/(SICI)1097-0258(19960315)15:5<449::AID-SIM173>3.0.CO;2-X

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  26 in total

1.  A decision-tree approach to cost comparison of newborn screening strategies for cystic fibrosis.

Authors:  Janelle Wells; Marjorie Rosenberg; Gary Hoffman; Michael Anstead; Philip M Farrell
Journal:  Pediatrics       Date:  2012-01-30       Impact factor: 7.124

2.  Genetic variation of SCNN1A influences lung diffusing capacity in cystic fibrosis.

Authors:  Sarah E Baker; Eric C Wong; Courtney M Wheatley; William T Foxx-Lupo; Marina G Martinez; Mary A Morgan; Ryan Sprissler; Wayne J Morgan; Eric M Snyder
Journal:  Med Sci Sports Exerc       Date:  2012-12       Impact factor: 5.411

3.  Respiratory syncytial virus engineered to express the cystic fibrosis transmembrane conductance regulator corrects the bioelectric phenotype of human cystic fibrosis airway epithelium in vitro.

Authors:  Anna R Kwilas; Mark A Yednak; Liqun Zhang; Rachael Liesman; Peter L Collins; Raymond J Pickles; Mark E Peeples
Journal:  J Virol       Date:  2010-05-26       Impact factor: 5.103

Review 4.  Cataplexy associated with narcolepsy: epidemiology, pathophysiology and management.

Authors:  Michael J Thorpy
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

5.  Newborn screening for cystic fibrosis: Polish 4 years' experience with CFTR sequencing strategy.

Authors:  Agnieszka Sobczyńska-Tomaszewska; Mariusz Ołtarzewski; Kamila Czerska; Katarzyna Wertheim-Tysarowska; Dorota Sands; Jarosław Walkowiak; Jerzy Bal; Tadeusz Mazurczak
Journal:  Eur J Hum Genet       Date:  2012-08-15       Impact factor: 4.246

Review 6.  Duration of intravenous antibiotic therapy in people with cystic fibrosis.

Authors:  Amanda Plummer; Martin Wildman; Tim Gleeson
Journal:  Cochrane Database Syst Rev       Date:  2016-09-01

7.  Nonparametric estimation of the mean function for recurrent event data with missing event category.

Authors:  Feng-Chang Lin; Jianwen Cai; Jason P Fine; Huichuan J Lai
Journal:  Biometrika       Date:  2013       Impact factor: 2.445

8.  Electronic monitoring reveals highly variable adherence patterns in patients prescribed ivacaftor.

Authors:  Christopher M Siracusa; Jamie Ryan; Lisa Burns; Yu Wang; Nanhua Zhang; John P Clancy; Dennis Drotar
Journal:  J Cyst Fibros       Date:  2015-06-11       Impact factor: 5.482

Review 9.  Pneumococcal vaccines for cystic fibrosis.

Authors:  Laura Burgess; Kevin W Southern
Journal:  Cochrane Database Syst Rev       Date:  2016-09-22

10.  Early anti-pseudomonal acquisition in young patients with cystic fibrosis: rationale and design of the EPIC clinical trial and observational study'.

Authors:  Miriam M Treggiari; Margaret Rosenfeld; Nicole Mayer-Hamblett; George Retsch-Bogart; Ronald L Gibson; Judy Williams; Julia Emerson; Richard A Kronmal; Bonnie W Ramsey
Journal:  Contemp Clin Trials       Date:  2009-01-15       Impact factor: 2.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.